Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

3 Biotech Stocks to Jumpstart Your Portfolio Gains

The biotech industry is poised for robust growth due to increasing demand for personalized treatments, rising prevalence of chronic diseases, heightened investments in R&D, and advancements in technology. Therefore, investors could consider buying fundamentally strong biotech stocks Innoviva (INVA), ANI Pharmaceuticals (ANIP), and United Therapeutics (UTHR). Read more.

StockNews.com

US pharma group opposing abortion pill restrictions also backs Republicans attacking drug

Group advocating to preserve FDA judgment in supreme court case also gave $125,000 to Republicans opposing mifepristone

The Guardian - US

Biden Spotlights Drug Prices, Medicare, Social Security in State of the Union

Biden calls for expanding Medicare drug price negotiations to include up to 500 drugs over next decade.

Kiplinger

From analysis to the latest developments in health,
read the most diverse news in one place.

Chemicals Giant Bayer Rules Out Break-up 'For Now' After Huge Loss

CEO Bill Anderson, hired last year to help steer the troubled group in a new direction, ruled out any imminent break-up of the company -- despite mounting pressure from activist investors.

International Business Times

Supreme Court’s ban on Patanjali ads | Explained

The Bench also issued a contempt notice against the company and its Managing Director Acharya Balkrishna for failing to adhere to directions passed in November last year. The “entire country has been taken for a ride”, the Bench said, while reprimanding the Union Government for its failure to take “urgent…

The Hindu

CVS and Walgreens to start dispensing abortion pill in states where it's legal

CVS will start filling prescriptions for mifepristone in Massachusetts and Rhode Island. Walgreens will start in New York, Pennsylvania, Massachusetts, California and Illinois.

WEKU

Two of biggest US pharmacy chains to stock mifepristone abortion pill

Biden applauds decision by CVS and Walgreens to offer drug on prescription at stores in several US states where abortion is legal

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

GlaxoSmithKline boss’s pay package jumps 50% to £12.7m

Emma Walmsley’s deal, with a high share bonus payout, makes her one of top-paid CEOs in FTSE 100

The Guardian - UK

3 Pharma Stocks With Prescription for Stability and Value in March

Amid rising healthcare demand globally, advancements in precision medicine, and the booming e-pharmacy market, the pharmaceutical industry is expected to witness significant long-term growth. Hence, fundamentally sound pharma stocks Dr. Reddy’s Laboratories (RDY), Ipsen (IPSEY), and Johnson & Johnson (JNJ), which boast low beta values and attractive valuation metrics, might…

StockNews.com

3 Pharma Stocks to Consider for March Gains

The pharmaceutical industry is experiencing rapid growth due to rising healthcare spending, an aging population, several technological advancements, and a favorable regulatory environment. Thus, it could be ideal to invest in quality pharma stocks Perrigo (PRGO), OptiNose (OPTN), and Teva Pharmaceutical (TEVA) for solid gains. Keep reading….

StockNews.com

3 Biotech Stocks to Watch in March for Success

The biotech industry is set for strong growth amid the growing need for personalized treatments, the rising number of chronic diseases, increased investment in research, and the use of advanced technologies. Therefore, investors could consider adding fundamentally strong biotech stocks Acorda Therapeutics (ACOR), BioNTech (BNTX), and Jazz Pharmaceuticals (JAZZ) to…

StockNews.com

Plunge into Profits With These 3 Biotech Stocks

The biotech industry's robust growth potential is driven by substantial pharma research and development, swift technological advancements, and lucrative government support. Given this backdrop, quality biotech stocks ProQR Therapeutics N.V. (PRQR), Regeneron Pharmaceuticals (REGN), and Corcept Therapeutics (CORT) could be solid buys now. Read on….

StockNews.com

4 Sky-Rocketing Pharma Stocks to Watch

The pharmaceutical industry is experiencing significant growth due to the rising demand for quality healthcare and high-quality drugs. This surge is further supported by the rapid growth in the global elderly population and the increase in chronic illnesses. Therefore, investors could consider adding pharma stocks Spero Therapeutics (SPRO), Wave Life…

StockNews.com

3 Pharma Stocks to Anchor Your Portfolio

The pharma market is poised to thrive due to the continuous medicinal advancements to meet the escalating demand for chronic disease treatment, technological advancements, and increased research and development. Given this backdrop, quality pharma stocks Procaps Group S.A. (PROC), Supernus Pharmaceuticals (SUPN), and GSK plc (GSK) could be wise portfolio…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

Telangana to expand Genome Valley, set up three pharma villages, unveil new Life Sciences policy

Telangana's Chief Minister announces Genome Valley expansion with Rs.2,000 crore investment, creating five lakh new jobs in pharma villages and pharma villages in Vikarabad, Nalgonda and Medak.

The Guardian - UK

A quiet conspiracy is afoot to give FTSE 100 executives a pay rise

As the London market’s woes are blamed on remuneration, a new US benchmark is emerging

StockNews.com

3 Pharma Powerhouses for Long-Term Growth in 2024

Amid evolving technologies and strategic maneuvers, the pharma industry is set for paradigm-shifting growth, propelled by growing funding and drug discovery. Hence, fundamentally strong pharma stocks Collegium Pharmaceutical (COLL), AstraZeneca (AZN), and Merck & Co. (MRK) might be ideal buys this year for long-term growth. Read more….

Reason

Feds Make a Pharma Patent Grab

A Biden administration ploy could give the federal government control over drug prices.

Get all your
news in one place.

100's of premium titles.
One news app.

Marie Claire

As a low-maintenance beauty editor with frazzled hair, I can’t believe the results of this underrated Olaplex product

This is one smooth operator

Radio France Internationale

Drugs shortage sees France restart local production, target antibiotics use

The French government has published a roadmap to address a growing shortage of medicines. It provides doctors and pharmacists with tools to prescribe alternatives, urges the use of fewer antibiotics and jumpstarts local production of key drugs.

The Guardian - US

New York man pleads guilty to running ‘Breaking Bad-style’ meth lab

‘Brilliant’ scientist Matthew Leshinsky turned himself in after calling the police to report a burglary at his lab in Suffolk county

The Guardian - UK

AstraZeneca boss’s £17m pay package under fire

Corporate governance thinktank questions whether Pascal Soriot’s remuneration – 1,000 times the minimum wage – is justifiable

StockNews.com

Moderna (MRNA) Earnings Analysis: Buy or Watch for Gains?

Moderna’s (MRNA) mRNA platform is positioned to deliver significant long-term impact with its mRNA medicines, but declining sales amid plummeting demand for its COVID-19 vaccine, steep losses, and cash burn reflect uncertainty around its near-term prospects. As MRNA is set to release its fourth-quarter 2023 results this Thursday, let’s find…

StockNews.com

Pfizer (PFE) vs. Johnson & Johnson (JNJ) - Analyzing Pharma Stocks for Upside Potential

The pharmaceutical industry is expected to witness robust growth over the coming years due to growing healthcare needs and advancements in technology. Given this positive backdrop, let’s analyze the upside potential of pharma stocks Pfizer (PFE) and Johnson & Johnson (JNJ).

The Hindu

Brave new world: On the India-European Free Trade Association agreement and IPR

India must invest substantially more in fundamental research to incubate the local drug industry into the future

1 … 36 37 38 39

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.